Featured Research

from universities, journals, and other organizations

IV hormone infusion could treat common cause of infertility in women

Date:
May 4, 2014
Source:
European Society of Endocrinology
Summary:
Researchers have succeeded in restoring hormones essential for fertility that are commonly lost in women who exercise intensively, according to research. Fertility depends on a range of reproductive hormones. In females, one of these, called luteinising hormone is released from the brain in short bursts every 1-2 hours. When women undergo strict exercise regimes and restrict their calorific intake, energy is diverted away from maintaining their reproductive system.

Researchers have succeeded in restoring hormones essential for fertility that are commonly lost in women who exercise intensively, according to research presented today. The work, by researchers from Imperial College London, is presented this week at the European Congress of Endocrinology in Wrocłow, Poland.

Fertility depends on a range of reproductive hormones. In females, one of these, called luteinising hormone is released from the brain in short bursts every 1-2 hours. When women undergo strict exercise regimes and restrict their calorific intake, energy is diverted away from maintaining their reproductive system. This can lead to lower amounts of LH being released by the brain, resulting in loss of periods. This condition known as hypothalamic amenorrhea (HA) affects 1 in 100 women and 1 in 10 professional female athletes.

Kisspeptin is a hormone responsible for initiating pulses of LH. Previous studies have shown that women who have mutations in the gene coding for kisspeptin do not start puberty normally and can be infertile. In this study, five women between the ages of 18 and 40 suffering from HA were given 8-hour intravenous infusions of either kisspeptin or a saline placebo on six different occasions.

Researchers gave them a different dose of kisspeptin on each visit. At intermediate doses, women who received kisspeptin infusions released more LH and experienced an average of three times more LH pulses within 8 hours than those who received the placebo.

"We've shown that in the short term, IV infusions of kisspeptin at certain doses can restore the pulses of LH that are essential for female fertility," said Dr Channa Jayasena from Imperial College London who is the first-author on the study. The group plans to perform a larger study to confirm their findings. "The long-term aim is to determine whether kisspeptin could be used to treat certain forms of female infertility. If this is viable, it could provide an attractive and possibly less costly alternative to IVF," said Dr Jayasena.


Story Source:

The above story is based on materials provided by European Society of Endocrinology. Note: Materials may be edited for content and length.


Cite This Page:

European Society of Endocrinology. "IV hormone infusion could treat common cause of infertility in women." ScienceDaily. ScienceDaily, 4 May 2014. <www.sciencedaily.com/releases/2014/05/140504095316.htm>.
European Society of Endocrinology. (2014, May 4). IV hormone infusion could treat common cause of infertility in women. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/05/140504095316.htm
European Society of Endocrinology. "IV hormone infusion could treat common cause of infertility in women." ScienceDaily. www.sciencedaily.com/releases/2014/05/140504095316.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins